Johnson & Johnson
Johnson & Johnson JNJ.DE Peers
See (JNJ.DE) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| JNJ.DE | €129.26 | -0.74% | 311B | 16.81 | €7.69 | +3.62% |
| LLY.DE | €661.30 | -1.40% | 626.7B | 62.80 | €10.53 | +0.73% |
| 4AB.DE | €157.80 | -0.88% | 278.7B | 77.73 | €2.03 | +3.82% |
| ZEG.DE | €118.65 | -1.17% | 184B | 27.53 | €4.31 | +2.31% |
| 6MK.DE | €67.10 | -1.47% | 169B | 11.22 | €6.00 | +4.43% |
| AMG.DE | €237.85 | -0.73% | 127.9B | 24.93 | €9.54 | +3.56% |
| PFE.DE | €20.72 | -0.14% | 117.8B | 17.27 | €1.20 | +7.76% |
| PFE.F | €20.72 | +0.58% | 117.3B | 17.05 | €1.21 | +7.79% |
| GIS.DE | €94.15 | -0.03% | 117.1B | 22.74 | €4.14 | +3.11% |
| SNW.DE | €82.22 | -0.24% | 100.2B | 16.48 | €4.99 | +4.77% |
Stock Comparison
JNJ.DE vs LLY.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, LLY.DE has a market cap of 626.7B. Regarding current trading prices, JNJ.DE is priced at €129.26, while LLY.DE trades at €661.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas LLY.DE's P/E ratio is 62.80. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to LLY.DE's ROE of +0.77%. Regarding short-term risk, JNJ.DE is less volatile compared to LLY.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs 4AB.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, 4AB.DE has a market cap of 278.7B. Regarding current trading prices, JNJ.DE is priced at €129.26, while 4AB.DE trades at €157.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas 4AB.DE's P/E ratio is 77.73. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to 4AB.DE's ROE of +0.96%. Regarding short-term risk, JNJ.DE is less volatile compared to 4AB.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs ZEG.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, ZEG.DE has a market cap of 184B. Regarding current trading prices, JNJ.DE is priced at €129.26, while ZEG.DE trades at €118.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas ZEG.DE's P/E ratio is 27.53. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to ZEG.DE's ROE of +0.19%. Regarding short-term risk, JNJ.DE is less volatile compared to ZEG.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs 6MK.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, 6MK.DE has a market cap of 169B. Regarding current trading prices, JNJ.DE is priced at €129.26, while 6MK.DE trades at €67.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas 6MK.DE's P/E ratio is 11.22. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to 6MK.DE's ROE of +0.38%. Regarding short-term risk, JNJ.DE is less volatile compared to 6MK.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs AMG.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, AMG.DE has a market cap of 127.9B. Regarding current trading prices, JNJ.DE is priced at €129.26, while AMG.DE trades at €237.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas AMG.DE's P/E ratio is 24.93. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to AMG.DE's ROE of +0.66%. Regarding short-term risk, JNJ.DE is more volatile compared to AMG.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs PFE.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, PFE.DE has a market cap of 117.8B. Regarding current trading prices, JNJ.DE is priced at €129.26, while PFE.DE trades at €20.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas PFE.DE's P/E ratio is 17.27. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to PFE.DE's ROE of +0.09%. Regarding short-term risk, JNJ.DE is more volatile compared to PFE.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs PFE.F Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, PFE.F has a market cap of 117.3B. Regarding current trading prices, JNJ.DE is priced at €129.26, while PFE.F trades at €20.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas PFE.F's P/E ratio is 17.05. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to PFE.F's ROE of +0.09%. Regarding short-term risk, JNJ.DE is more volatile compared to PFE.F. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs GIS.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, GIS.DE has a market cap of 117.1B. Regarding current trading prices, JNJ.DE is priced at €129.26, while GIS.DE trades at €94.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas GIS.DE's P/E ratio is 22.74. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to GIS.DE's ROE of +0.25%. Regarding short-term risk, JNJ.DE is more volatile compared to GIS.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs SNW.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, SNW.DE has a market cap of 100.2B. Regarding current trading prices, JNJ.DE is priced at €129.26, while SNW.DE trades at €82.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas SNW.DE's P/E ratio is 16.48. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to SNW.DE's ROE of +0.08%. Regarding short-term risk, JNJ.DE is less volatile compared to SNW.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs BRM.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, BRM.DE has a market cap of 80.8B. Regarding current trading prices, JNJ.DE is priced at €129.26, while BRM.DE trades at €39.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas BRM.DE's P/E ratio is 17.04. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to BRM.DE's ROE of +0.32%. Regarding short-term risk, JNJ.DE is less volatile compared to BRM.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs BAYN.SG Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, BAYN.SG has a market cap of 25.1B. Regarding current trading prices, JNJ.DE is priced at €129.26, while BAYN.SG trades at €25.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas BAYN.SG's P/E ratio is N/A. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to BAYN.SG's ROE of -0.08%. Regarding short-term risk, JNJ.DE is less volatile compared to BAYN.SG. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs BAYN.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, BAYN.DE has a market cap of 25.1B. Regarding current trading prices, JNJ.DE is priced at €129.26, while BAYN.DE trades at €25.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas BAYN.DE's P/E ratio is -7.69. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to BAYN.DE's ROE of -0.10%. Regarding short-term risk, JNJ.DE is less volatile compared to BAYN.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs IDP.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, IDP.DE has a market cap of 15.7B. Regarding current trading prices, JNJ.DE is priced at €129.26, while IDP.DE trades at €107.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas IDP.DE's P/E ratio is 12.37. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to IDP.DE's ROE of +0.09%. Regarding short-term risk, JNJ.DE is more volatile compared to IDP.DE. This indicates potentially higher risk in terms of short-term price fluctuations for JNJ.DE.
JNJ.DE vs GS7.DE Comparison
JNJ.DE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, JNJ.DE stands at 311B. In comparison, GS7.DE has a market cap of 0. Regarding current trading prices, JNJ.DE is priced at €129.26, while GS7.DE trades at €20.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
JNJ.DE currently has a P/E ratio of 16.81, whereas GS7.DE's P/E ratio is 17.31. In terms of profitability, JNJ.DE's ROE is +0.30%, compared to GS7.DE's ROE of +0.34%. Regarding short-term risk, JNJ.DE is less volatile compared to GS7.DE. This indicates potentially lower risk in terms of short-term price fluctuations for JNJ.DE.